Smoking-related cotinine levels and host responses in chronic periodontitis

Journal of Periodontal Research

Volumn 49, Issue 5, 2014, Pages 642-651

  Ebersole, J L ^a   Steffen, M J ^a   Thomas, M V ^a   Al Sabbagh, M ^a  

^a UNIVERSITY OF KENTUCKY COLLEGE OF DENTISTRY   (United States)

Author keywords

Cotinine; Inflammation; Periodontitis; Smoking

Indexed keywords

AUTACOID; BACTERIUM ANTIBODY; COTININE; IL10 PROTEIN, HUMAN; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 1BETA; PEROXIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTAGLANDIN E2; SERPINE1 PROTEIN, HUMAN;

ACTINOMYCES; ADULT; AGED; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; BLOOD; CAPNOCYTOPHAGA; CASE CONTROL STUDY; CHEMISTRY; COMPARATIVE STUDY; FEMALE; GINGIVITIS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PREVOTELLA; SALIVA; SMOKING; STREPTOCOCCUS SANGUINIS; TREPONEMA DENTICOLA; VEILLONELLA; YOUNG ADULT;

ACTINOMYCES; ADULT; AGED; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANTIBODIES, BACTERIAL; CAPNOCYTOPHAGA; CASE-CONTROL STUDIES; COTININE; DINOPROSTONE; FEMALE; GINGIVITIS; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; PERIODONTITIS; PEROXIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PORPHYROMONAS GINGIVALIS; PREVOTELLA; SALIVA; SMOKING; STREPTOCOCCUS SANGUIS; TREPONEMA DENTICOLA; VEILLONELLA; YOUNG ADULT;

EID: 84908599044     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/jre.12146     Document Type: Article

References (80)

1. Seymour GJ, Ford PJ, Cullinan MP, Leishman S, Yamazaki K. Relationship between periodontal infections and systemic disease. Clin Microbiol Infect 2007;13(Suppl 4):3-10.
2. Belstrom D, Damgaard C, Nielsen CH, Holmstrup P. Does a causal relation between cardiovascular disease and periodontitis exist? Microbes Infect 2012;14:411-418.
3. Jimenez M, Krall EA, Garcia RI, Vokonas PS, Dietrich T. Periodontitis and incidence of cerebrovascular disease in men. Ann Neurol 2009;66:505-512.
4. Kinane D, Bouchard P. Periodontal diseases and health: consensus report of the sixth European workshop on periodontology. J Clin Periodontol 2008;35:333-337.
5. Preshaw PM, Alba AL, Herrera D et al. Periodontitis and diabetes: a two-way relationship. Diabetologia 2012;55:21-31.
6. Bobetsis YA, Barros SP, Offenbacher S. Exploring the relationship between periodontal disease and pregnancy complications. J Am Dent Assoc 2006;137(Suppl 2):7S-13S.
7. Noble JM, Borrell LN, Papapanou PN, Elkind MS, Scarmeas N, Wright CB. Periodontitis is associated with cognitive impairment among older adults: analysis of NHANES-III. J Neurol Neurosurg Psychiatry 2009;80:1206-1211.
8. Loe H, Theilade E, Jensen SB. Experimental gingivitis in man. J Periodontol 1965;36:177-187.
9. Eke PI, Thornton-Evans G, Dye B, Genco R. Advances in surveillance of periodontitis: the centers for disease control and prevention periodontal disease surveillance project. J Periodontol 2012;83:1337-1342.
10. Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ. Cdc periodontal disease Surveillance workgroup: James Beck GDRP. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res 2012;91:914-920.
11. Zarco MF, Vess TJ, Ginsburg GS. The oral microbiome in health and disease and the potential impact on personalized dental medicine. Oral Dis 2012;18:109-120.
12. Teles FR, Teles RP, Uzel NG et al. Early microbial succession in redeveloping dental biofilms in periodontal health and disease. J Periodontal Res 2012;47:95-104.
13. Cobb CM. Microbes, inflammation, scaling and root planing, and the periodontal condition. J Dent Hyg 2008;82(Suppl 3):4-9.
14. Kinane DF, Bartold PM. Clinical relevance of the host responses of periodontitis. Periodontology 2000;2007:278-293.
15. Kumar PS, Leys EJ, Bryk JM, Martinez FJ, Moeschberger ML, Griffen AL. Changes in periodontal health status are associated with bacterial community shifts as assessed by quantitative 16S cloning and sequencing. J Clin Microbiol 2006;44:3665-3673.
16. Paster BJ, Dewhirst FE. Molecular microbial diagnosis. Periodontology 2000;2009:38-44.
17. Paster BJ, Olsen I, Aas JA, Dewhirst FE. The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontology 2000;2006:80-87.
18. Edelman SM, Kasper DL. Symbiotic commensal bacteria direct maturation of the host immune system. Curr Opin Gastroenterol 2008;24:720-724.
19. Van Dyke TE, Sheilesh D. Risk factors for periodontitis. J Int Acad Periodontol 2005;7:3-7.
20. Chambrone L, Preshaw PM, Rosa EF et al. Effects of smoking cessation on the outcomes of non-surgical periodontal therapy: a systematic review and individual patient data meta-analysis. J Clin Periodontol 2013;40:607-615.
21. Thomson WM, Sheiham A, Spencer AJ. Sociobehavioral aspects of periodontal disease. Periodontology 2000;2012:54-63.
22. Filoche SK, Cornford E, Gaudie W, Wong M, Heasman P, Thomson WM. Smoking, chronic periodontitis and smoking cessation support: reviewing the role of dental professionals. N Z Dent J 2010;106:74-77.
23. Dietrich T, Bernimoulin JP, Glynn RJ. The effect of cigarette smoking on gingival bleeding. J Periodontol 2004;75:16-22.
24. Dietrich T, Hoffmann K. A comprehensive index for the modeling of smoking history in periodontal research. J Dent Res 2004;83:859-863.
25. Matthews JB, Chen FM, Milward MR et al. Effect of nicotine, cotinine and cigarette smoke extract on the neutrophil respiratory burst. J Clin Periodontol 2011;38:208-218.
26. Matthews JB, Chen FM, Milward MR, Ling MR, Chapple IL. Neutrophil superoxide production in the presence of cigarette smoke extract, nicotine and cotinine. J Clin Periodontol 2012;39:626-634.
27. Tomar SL, Asma S. Smoking-attributable periodontitis in the United States: findings from NHANES III. National health and nutrition examination survey. J Periodontol 2000;71:743-751.
28. Palmer RM, Wilson RF, Hasan AS, Scott DA. Mechanisms of action of environmental factors - tobacco smoking. J Clin Periodontol 2005;32(Suppl 6):180-195.
29. Yeh HL, Kuo LT, Sung FC, Chiang CW, Yeh CC. GSTM1, GSTT1, GSTP1, and GSTA1 genetic variants are not associated with coronary artery disease in Taiwan. Gene 2013;523:64-69.
30. Benakanakere M, Kinane DF. Innate cellular responses to the periodontal biofilm. Front Oral Biol 2012;15:41-55.
31. Graves D. Cytokines that promote periodontal tissue destruction. J Periodontol 2008;79:1585-1591.
32. Ebersole JL, Dawson DR 3rd, Morford LA, Peyyala R, Miller CS, Gonzalez OA. Periodontal disease immunology: 'double indemnity' in protecting the host. Periodontology 2000;2013:163-202.
33. Ebersole JL, Cappelli D. Acute-phase reactants in infections and inflammatory diseases. Periodontology 2000;2000:19-49.
34. Malik A, Batra JK. Antimicrobial activity of human eosinophil granule proteins: involvement in host defence against pathogens. Crit Rev Microbiol 2012;38:168-181.
35. Garlet GP. Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints. J Dent Res 2010;89:1349-1363.
36. Ebersole JL, Holt SC, Hansard R, Novak MJ. Microbiologic and immunologic characteristics of periodontal disease in Hispanic americans with type 2 diabetes. J Periodontol 2008;79:637-646.
37. Ebersole JL. Humoral immune responses in gingival crevice fluid: local and systemic implications. Periodontology 2000;2003:135-166.
38. Papapanou PN, Neiderud AM, Disick E, Lalla E, Miller GC, Dahlen G. Longitudinal stability of serum immunoglobulin G responses to periodontal bacteria. J Clin Periodontol 2004;31:985-990.
39. Vaughan AT, Gorringe A, Davenport V, Williams NA, Heyderman RS. Absence of mucosal immunity in the human upper respiratory tract to the commensal bacteria Neisseria lactamica but not pathogenic Neisseria meningitidis during the peak age of nasopharyngeal carriage. J Immunol 2009;182:2231-2240.
40. Singer RE, Moss K, Beck JD, Offenbacher S. Association of systemic oxidative stress with suppressed serum IgG to commensal oral biofilm and modulation by periodontal infection. Antioxid Redox Signal 2009;11:2973-2983.
41. Cappelli D, Steffen MJ, Holt SC, Ebersole JL. Periodontitis in pregnancy: clinical and serum antibody observations from a baboon model of ligature-induced disease. J Periodontol 2009;80:1154-1165.
42. Rocchietta I, Nisand D. A review assessing the quality of reporting of risk factor research in implant dentistry using smoking, diabetes and periodontitis and implant loss as an outcome: critical aspects in design and outcome assessment. J Clin Periodontol 2012;39(Suppl 12):114-121.
43. Snider TN, Cottrell D, Batal H. Summary of current consensus on the effect of smoking on implant therapy. J Mass Dental Soc 2011;59:20-22.
44. Huttunen R, Heikkinen T, Syrjanen J. Smoking and the outcome of infection. J Intern Med 2011;269:258-269.
45. Ismail AI, Burt BA, Eklund SA. Epidemiologic patterns of smoking and periodontal disease in the United States. J Am Dent Assoc 1983;106:617-621.
46. Machtei EE, Dunford R, Hausmann E et al. Longitudinal study of prognostic factors in established periodontitis patients. J Clin Periodontol 1997;24:102-109.
47. Haber J. Smoking is a major risk factor for periodontitis. Curr Opin Periodontol 1994;1:12-18.
48. Bolin A, Lavstedt S, Frithiof L, Henrikson CO. Proximal alveolar bone loss in a longitudinal radiographic investigation. IV. Smoking and some other factors influencing the progress in individuals with at least 20 remaining teeth. Acta Odontol Scand 1986;44:263-269.
49. Grossi SG, Skrepcinski FB, DeCaro T, Zambon JJ, Cummins D, Genco RJ. Response to periodontal therapy in diabetics and smokers. J Periodontol 1996;67:1094-1102.
50. Fiorini T, Musskopf ML, Oppermann RV, Susin C. Is there a positive effect of smoking cessation on periodontal health? a systematic review J Periodontol 2013. [Epub ahead of print].
51. Scott DA, Singer DL. Suppression of overt gingival inflammation in tobacco smokers - clinical and mechanistic considerations. Int J Dent Hyg 2004;2:104-110.
52. Genco RJ, Borgnakke WS. Risk factors for periodontal disease. Periodontology 2000;2013:59-94.
53. Hayman L, Steffen MJ, Stevens J et al. Smoking and periodontal disease: discrimination of antibody responses to pathogenic and commensal oral bacteria. Clin Exp Immunol 2011;164:118-126.
54. Graves DT, Oates T, Garlet GP. Review of osteoimmunology and the host response in endodontic and periodontal lesions. J Oral Microbiol 2011;3:1-15.
55. Kornman KS. Interleukin 1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of aging. Am J Clin Nutr 2006;83:475S-483S.
56. Brett PM, Zygogianni P, Griffiths GS et al. Functional gene polymorphisms in aggressive and chronic periodontitis. J Dent Res 2005;84:1149-1153.
57. Javed F, Al-Askar M, Al-Hezaimi K. Cytokine profile in the gingival crevicular fluid of periodontitis patients with and without type 2 diabetes: a literature review. J Periodontol 2012;83:156-161.
58. Tsai CC, Hong YC, Chen CC, Wu YM. Measurement of prostaglandin E2 and leukotriene B4 in the gingival crevicular fluid. J Dent 1998;26:97-103.
59. Tanaka H, Tanabe N, Shoji M et al. Nicotine and lipopolysaccharide stimulate the formation of osteoclast-like cells by increasing macrophage colony-stimulating factor and prostaglandin E2 production by osteoblasts. Life Sci 2006;78:1733-1740.
60. Salvi GE, Yalda B, Collins JG et al. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. J Periodontol 1997;68:127-135.
61. Lamster IB, Novak MJ. Host mediators in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. Crit Rev Oral Biol Med 1992;3:31-60.
62. Larsson L, Thorbert-Mros S, Rymo L, Berglundh T. Interleukin-10 genotypes of the -1087 single nucleotide polymorphism influence sp1 expression in periodontitis lesions. J Periodontol 2011;82:1376-1382.
63. Berglundh T, Donati M, Hahn-Zoric M, Hanson LA, Padyukov L. Association of the -1087 IL 10 gene polymorphism with severe chronic periodontitis in Swedish Caucasians. J Clin Periodontol 2003;30:249-254.
64. Lappin DF, MacLeod CP, Kerr A, Mitchell T, Kinane DF. Anti-inflammatory cytokine IL-10 and T cell cytokine profile in periodontitis granulation tissue. Clin Exp Immunol 2001;123:294-300.
65. Buduneli N, Buduneli E, Kardesler L, Lappin D, Kinane DF. Plasminogen activator system in smokers and non-smokers with and without periodontal disease. J Clin Periodontol 2005;32:417-424.
66. Kinnby B. The plasminogen activating system in periodontal health and disease. Biol Chem 2002;383:85-92.
67. Taylor BA, Tofler GH, Carey HM et al. Full-mouth tooth extraction lowers systemic inflammatory and thrombotic markers of cardiovascular risk. J Dent Res 2006;85:74-78.
68. Taylor B, Tofler G, Morel-Kopp MC et al. The effect of initial treatment of periodontitis on systemic markers of inflammation and cardiovascular risk: a randomized controlled trial. Eur J Oral Sci 2010;118:350-356.
69. Behle JH, Sedaghatfar MH, Demmer RT et al. Heterogeneity of systemic inflammatory responses to periodontal therapy. J Clin Periodontol 2009;36:287-294.
70. Strongin AY. Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy. Biochim Biophys Acta 2010;1803:133-141.
71. Ghosh AK, Vaughan DE. PAI-1 in tissue fibrosis. J Cell Physiol 2012;227:493-507.
72. Jankun J, Al-Senaidy A, Skrzypczak-Jankun E. Can inactivators of plasminogen activator inhibitor alleviate the burden of obesity and diabetes? (Review). Int J Mol Med 2012;29:3-11.
73. Ma Z, Paek D, Oh CK. Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation. Clin Exp Allergy 2009;39:1136-1144.
74. Paulus P, Jennewein C, Zacharowski K. Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis? Biomarkers 2011;16(Suppl 1):S11-S21.
75. Klebanoff SJ. Myeloperoxidase. Proc Assoc Am Physicians 1999;111:383-389.
76. Lau D, Baldus S. Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacol Ther 2006;111:16-26.
77. Rudolph TK, Rudolph V, Baldus S. Contribution of myeloperoxidase to smoking-dependent vascular inflammation. Proc Am Thorac Soc 2008;5:820-823.
78. Buduneli N, Kardesler L, Isik H et al. Effects of smoking and gingival inflammation on salivary antioxidant capacity. J Clin Periodontol 2006;33:159-164.
79. Apatzidou DA, Riggio MP, Kinane DF. Impact of smoking on the clinical, microbiological and immunological parameters of adult patients with periodontitis. J Clin Periodontol 2005;32:973-983.
80. Tangada SD, Califano JV, Nakashima K et al. The effect of smoking on serum IgG2 reactive with Actinobacillus actinomycetemcomitans in early-onset periodontitis patients. J Periodontol 1997;68:842-850.